G1 Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. GTHX has around 2.9M shares in the U.S. ETF market. The largest ETF holder of GTHX is the iShares Russell 2000 ETF (IWM), with approximately 708.48K shares. Investors may also find of interest that the ETF with the largest allocation to GTHX stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.90%. On average, U.S. ETFs allocate 0.12% of GTHX to their portfolios.
Additionally, GTHX is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GTHX as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.